As the $.SPX(.SPX)$ approaches its all-time high, some undervalued components like $Pfizer(PFE)$ $AbbVie(ABBV)$ are flying under the radar. Both of these healthcare stocks boast dividend yields over 3% and are poised for further increases, making them likely candidates to outperform the S&P 500 in the next decade.1. $Pfizer(PFE)$Last December, Pfizer raised its dividend for the 15th consecutive year, with a current yield of 5.8%. Even without additional hikes, this stock can provide substantial passive income. With many new patented drugs in the pipeline, investors can reasonably expect steady quarterly dividend increa
Take Profit as S&P Hits 5800 or Hold Till 6000?
As the stock market hits record highs more than 40 times this year, there are concerns that history might repeat itself and another financial crisis could occur. ---------------- Will S&P 500 hit 6000 by year-end as institutions predict? Would you take profit and stay cautious ahead or hold till the year-end?
+ Follow
+83